Clinical Trials Directory

Trials / Terminated

TerminatedNCT02360150

Evaluation of Myocardial Viability : Dual Energy Cardiac CT vs. Cardiac MRI

Evaluation of Myocardial Viability in Late Presentation Myocardial Infarction: Dual Energy Cardiac CT vs. Cardiac MRI.

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
31 (actual)
Sponsor
University Hospital, Rouen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is therefore to show that associated with cardiac angiography echocardiography, in myocardial seen late, would provide the information necessary for the decision revascularization, in a timely manner. This would allow the patient to avoid duplication of tests including risk related to coronary angiography (bleeding complications, stroke ...) and those related to the implantation of coronary stent (stent) without expected earnings in case of non-viability . This would also reduce the length of hospital stay and costs due to numerous reviews.

Detailed description

Percutaneous coronary intervention is not recommended in stable patients with late presentation myocardial infarction, and myocardial viability needs to be evaluated before the procedure. The aim of the study is to evaluate the sensibility and specificity of dual-energy CT for the evaluation of myocardial viability in comparison to cardiac MRI. The experimental procedure is limited to a second CT acquisition performed 10 minutes in dual energy mode. Sensitivity and Specificity of delayed enhancement \>50% of myocardial thickness provided by dual-energy CT will be evaluated in comparison to cardiac MRI.

Conditions

Interventions

TypeNameDescription
RADIATIONsecond propeller arm scannerThe experimental procedure is to conduct a second helical scanner strictly centered on the heart, 10 minutes after the first helix without inject contrast medium, to assess late enhancement.

Timeline

Start date
2015-01-10
Primary completion
2016-10-07
Completion
2016-10-07
First posted
2015-02-10
Last updated
2026-04-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02360150. Inclusion in this directory is not an endorsement.